0001485003-16-000133.txt : 20160712 0001485003-16-000133.hdr.sgml : 20160712 20160712163346 ACCESSION NUMBER: 0001485003-16-000133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160709 FILED AS OF DATE: 20160712 DATE AS OF CHANGE: 20160712 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tubridy Karen L CENTRAL INDEX KEY: 0001589888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161764232 MAIL ADDRESS: STREET 1: ELEVEN BIOTHERAPEUTICS, INC. STREET 2: 215 FIRST STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_146835561327274.xml FORM 4 X0306 4 2016-07-09 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001589888 Tubridy Karen L C/O ELEVEN BIOTHERAPEUTICS, INC., 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 0 1 0 0 Chief Development Officer Stock Option (Right to Buy) 0.28 2016-07-09 4 A 0 13328 0 A 2016-07-09 2026-02-24 Common Stock 13328.0 26672 D On February 25, 2016, the reporting person was granted an option to purchase 40,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 13,328 shares.The option had previously vested with respect to 13,344 shares. /s/ John J. McCabe as attorney-in-fact 2016-07-12